Exabis Library
Welcome to the e-CCO Library!
P352: Melanoma in a population-based Australian inflammatory bowel disease cohort
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P352: Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P352: TDM of infliximab in IBD-patients: which pharmacokinetic marker to use?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P352: Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn’s disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P353 Assessing compliance to screening for infectious diseases and vaccination in patients newly diagnosed with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P353: Aberrant brain structural large-scale connectome in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P353: Agreement between patients, senior and junior physicians on disease activity and burden scoring in inflammatory bowel disease, using a tele-monitoring platform
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P353: Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea: An update
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P353: Endoscopy-based management within the first year after surgery decreases the risk of clinical and surgical postoperative recurrences in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P353: Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registry
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P353: Pan-enteric capsule endoscopy enables assessment of mucosal healing after biologic treatment initiation in Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P353: Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P354 Objectively measured time spent sitting, standing upright, and stepping is associated with disease severity and faecal calprotectin in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P354: A prospective randomised study: 2 mg/kg/d of azathioprine is an appropriate dosage for Chinese patients with Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P354: Application of the clinical decision support tool to predict treatment outcomes in Crohn's Disease patients treated with vedolizumab subcutaneous formulation
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P354: Early treatment versus active surveillance after ileocolic resection in Crohn’s disease: a retrospective cohort study.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P354: Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P354: Perceived Quality of Care is associated to quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD centre
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P354: Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A new tool to measure disease-specific distress
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P354: The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM